The present study aims to assess the serum ceruloplasmin-to-albumin ratio in patients with pulmonary tuberculosis (PTB), investigating its potential as a diagnostic and prognostic marker in TB therapy. The gene discussed is ALB; the disease is pulmonary tuberculosis.